Journey Medical Corporation (DERM) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Journey Medical Corporation (DERM) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $141.9M, listed on NASDAQ, employing roughly 41 people, carrying a beta of 1.03 to the broader market. Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. Led by Claude Maraoui, public since 2021-11-12.
Snapshot as of May 15, 2026.
- Spot Price
- $6.25
- Total OI
- 1.7K